Elena Becker-Barroso

Editor. Personal account.

[Elena Becker-Barroso @beckerbarroso]

New Profile pic courtesy of @combatstrokeSL

[Elena Becker-Barroso @beckerbarroso]

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) awarded Lysoway Therapeutics $3.4 million in funding to support therapy targeting the TMEM175 protein. ="https://t.co/YomY3wgmMQ" class="read-more">Read More</a> https://t.co/YomY3wgmMQ

[Elena Becker-Barroso @beckerbarroso]

Brain mapping effort searches for roots of Parkinson’s and other diseases | Science | AAAS https://t.co/rbl8CMsXz7

[The Lancet @TheLancet]

A study in The Lancet examines the impact of ocrelizumab in older patients with primary progressive multiple sclerosis & those with more advance disease. It finds that ocrelizumab was superior to placebo, with stronger effect on hand function (see infographic).

Read more: https://t.co/5h7n4oNNhJ

[British Normandy Memorial @britishmemorial]

Wreath laying by 100-year-old Henry Rice off the Normandy coast.

#DDay82 commemorations have begun.

[European Research Council (ERC) @ERC_Research]

A change in the brain's immune cells may help explain why some people with Alzheimer's disease develop dementia while others remain cognitively healthy.
New discovery from Bart De Stroop @KU_Leuven & team @VIB, @UKDRI & @muna_tx.

Learn more 🔗 https://t.co/nJ4vVHAjTX

[The Lancet @TheLancet]

Ocrelizumab, a monoclonal antibody, is already approved for people with relapsing or primary progressive multiple sclerosis.

In The Lancet, two phase 3 trials suggest a higher dose of ocrelizumab did not further reduce the risk of disability progression; however, data confirm the favourable benefit–risk profile of 600 mg ocrelizumab.

Read more: https://t.co/7MyHM9x6lR

[Nat Rev Neurology @NatRevNeurol]

Our June issue, which includes articles on chronic traumatic encephalopathy, plasma biomarkers for Alzheimer disease, and the long-term neurological effect of SARS-CoV-2 infection, is now live! https://t.co/HCmnpdCtKO

[Brain @Brain1878]

New issue of Brain now online! https://t.co/RI4U13usu5

[Neuron @NeuroCellPress]

New issue of Neuron is now online! This week's issue is a mini Special Issue on AI. It features Perspectives from Srini Narayanan and colleagues, Blake Richards and colleagues, as well as Q&As with Danilo Bzdok and David Sussillo.
https://t.co/FRK7jiLsqn

[Embassy of Spain UK @EmbSpainUK]

We will always remember Ignacio Echeverría and all the victims of the London Bridge terrorist attack.

On the 9th anniversary of the tragedy, we have gathered at London Bridge to lay a wreath in their memory.

Always in our hearts. 🇪🇸🇬🇧

[Elena Becker-Barroso @beckerbarroso]

Two-thirds of the most severe patients with anti-NMDAR encephalitis recover https://t.co/7dRrBwW7Gk via @hospitalclinic

[Elena Becker-Barroso @beckerbarroso]

https://t.co/qHYpSpJwib

[Jonathan Kipnis 🟦 @jonykipnis]

https://t.co/QQS4yRjlJ5 On the cover: In this issue of Neuron, Du et al. @DuSiling show that repeated microglial depletion enables peripheral monocytes from both the blood and skull bone marrow to infiltrate the brain and engraft as monocyte-derived macrophages with distinct identities. Inspired by a passage from the Zuo Zhuan (“The first beat of the drum rouses the soldiers’ spirits; the second weakens their resolve; by the third, they are exhausted”), the artwork depicts three rounds of microglial depletion gradually exhausting the endogenous microglial niche. The two advancing armies represent distinct peripheral sources of invading cells: one arriving from the blood, illustrated by the army bearing the red flag, and the other emerging from the skull bone marrow, portrayed as descending from the mountains. Artist credit: Ying Xu.

[ESC Council on Stroke Chairperson @ESCStrokeChair]

Excellent Clinical Practice article in @NEJM on secondary prevention after ischemic #stroke.

A practical case vignette summarizing contemporary strategies for risk factor management and mechanism-specific prevention.

🔗 https://t.co/KH1KbJx2ZI
@JacopoImberti

[Jacky Ganguly @JackyGanguly]

Genetic Prion diseases @smead2 @TheLancetNeuro
- Not to miss Diarrhoea-Dysautonomia phenotype
#neurotwitter

[Neurochecklists @neurochecklists]

We have just updated our Bell’s palsy clinical features checklist with this paper https://t.co/uVl6thQFTD

[Esclerosis Múltiple @esclerosiseme]

¡Buenas noticias para empezar el #DiaMundialEsclerosisMultiple ! Gracias por tu gran trabajo

[Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM @agingdoc1]

Cognitive resilience in ageing: determinants and interventions

https://t.co/ZPRJHnZf7W

[Neurología HUVR @neuroHUVR]

Porque el tiempo es cerebro ⏱️🧠

[Instituto Murciano de Investigación Biosanitaria @IMIB_RMurcia]

🧑🏻‍⚕️Hoy se conmemora el Día de la Investigación Hospitalaria, una fecha que reconoce el valor estratégico de la ciencia y del conocimiento generado desde nuestros hospitales para transformar la asistencia sanitaria y mejorar la vida de las personas @ANIH_1